A bill that the NRLN has supported, S. 974, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act, was passed by the Senate Judiciary Committee by a 16 to 5 vote on June 14. The bill had been in the Judiciary Committee since it was introduced by Vermont Senator Patrick Leahy on April 27, 2017.
We need to urge our Senators to support bringing the bill to the Senate floor for a vote very soon, then they should vote for the bill and send it to the House where there is a companion bill.
The CREATES Act targets abusive delay tactics that are being used by brand-name pharmaceutical companies to block market entry of more affordable generic drugs.
Click here to access the NRLN’s sample letter urging U.S. Senators to pass the CREATES Act.